Previous Article | Next Article 
Journal of Virology, July 2001, p. 5949-5957, Vol. 75, No. 13
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.13.5949-5957.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Human Cytomegalovirus Chemokine Receptor Gene US28
Is Transcribed in Latently Infected THP-1 Monocytes
Patrick S.
Beisser,*
Lysiane
Laurent,
Jean-Louis
Virelizier, and
Susan
Michelson
Unité d'Immunologie Virale, Institut
Pasteur, 75274 Paris Cedex 15, France
Received 29 November 2000/Accepted 29 March 2001
 |
ABSTRACT |
The human cytomegalovirus (HCMV) US28 gene product, pUS28, is a G
protein-coupled receptor that interacts with both CC and CX3C chemokines. To date, the role of pUS28 in immune
evasion and cell migration has been studied only in cell types that can establish productive HCMV infection. We show that HCMV can latently infect THP-1 monocytes and that during latency US28 is transcribed. We
also show that the transcription is sustained during differentiation of
the THP-1 monocytes. Since cells expressing pUS28 were previously shown
to adhere to immobilized CX3C chemokines (C. A. Haskell, M. D. Cleary, and I. F. Charo, J. Biol. Chem.
275:34183-34189, 2000), we hypothesize that latently infected
circulating monocytes express pUS28, thereby enabling adhesion of these
cells to CX3C-exposing endothelium. Consequently, the
US28-encoded chemokine receptor may play an important role in
dissemination of latent HCMV.
 |
INTRODUCTION |
The human cytomegalovirus (HCMV)
genome contains four G-protein-coupled receptor-like genes, UL33, UL78,
US27, and US28 (8, 11). The US28-encoded G-protein-coupled
receptor pUS28 appears to be functional in many different respects. (i)
It was identified as a chemokine receptor capable of binding the CC
chemokines RANTES, MCP-1, MCP-3, MIP1-
, and MIP1-
(2, 10,
21, 26), as well as soluble forms of the CX3C
chemokine fractalkine (18). Upon interaction with the CC
chemokines, pUS28 induces Ca2+ mobilization and
extracellular signal-related kinase 2 activation (2, 10, 21,
26). In addition, transient expression of pUS28 leads to
constitutive activation of both phospholipase C and NF-
B signaling
(6). In this system, fractalkine acts as an inverse
agonist for pUS28 (6). (ii) Transient, high-level expression of pUS28 in smooth muscle cells induces chemokinesis in the
presence of MCP-1 and chemotaxis within a RANTES gradient (38). (iii) Expression of pUS28 leads to internalization
of RANTES and MCP-1 in both HCMV-infected fibroblasts and endothelial cells (3, 4). Thus, this receptor acts as a CC-chemokine sink, possibly enabling HCMV-infected cells to evade immune
surveillance. (iv) The chemokine receptor pUS28 is a coreceptor for
several human immunodeficiency virus strains (27, 32) and
can elicit cell-to-cell fusion upon interaction with several types of
viral envelope proteins (33). (v) The expression of pUS28
on the cell surface of murine pre-B-cell line 300-19 can establish cell
rolling and adhesion to a fixed fractalkine surface (15).
If pUS28 is expressed on the surface of HCMV-infected leukocytes, then
it could play an important role in virus trafficking from the
circulation to inflammatory sites. Particularly, the receptor could
mediate adhesion of circulating HCMV-infected monocytes to endothelial cells and subsequent transmission of HCMV from infected monocytes to
endothelial cells or, alternatively, transendothelial migration of
infected monocytes toward subendothelial tissues. To date, only a few
reports on US28 expression exist. US28-specific transcripts were
detected in peripheral blood mononuclear cells of some naturally infected individuals (31). In addition, US28-specific
transcripts were detected from 2 h to at least 24 h post-HCMV
infection (p.i.) of human foreskin fibroblasts (HFF) in vitro (4,
42, 44). Finally, US28-specific transcripts were detected in
HCMV-infected myeloid cell cultures
at 4 h p.i. in infected U373
MG astrocytoma cells and at 4 and 24 h p.i. in infected THP-1
monocytic cells (44). Interestingly, in many cell types of
myeloid origin, HCMV establishes latent infection, i.e., persistence of
nonreplicating viral genomic DNA in infected cells. Latent infection
occurs in progenitors of granulocytes, macrophages, and dendritic cells (13, 20), as well as in peripheral blood monocytes
(5) and immature macrophages (37). Recently,
HCMV major immediate early (MIE) gene-derived transcripts were
identified in latently infected monocyte or granulocyte progenitor
cells (20), as well as in bone marrow (BM)-derived
CD33+ CD14+ and CD33+
CD15+ cells (13). These cytomegalovirus
latency-associated transcripts (CLTs) have either a sense or an
antisense orientation relative to the conventional MIE coding region.
The sense CLTs have two specific transcription start sites (LSS1 and
LSS2) within the MIE promoter-enhancer region, upstream of the
productive-infection transcription start site (PSS) (Fig.
1). The function of neither CLTs nor
their corresponding gene products is known. To date, CLTs are the only
transcripts identified in latently infected cells. Here we report a
system for studying HCMV gene expression in latently infected monocytic
THP-1 cells. Using this system, we demonstrate that US28, like the MIE
gene, is transcribed during both latent and productive HCMV infection.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
RT-PCR primers and their target transcripts. Schematic
representation of the HCMV Toledo genome and the relative positions of
the MIE gene and US28. Black boxes represent repeat regions of the
Toledo genome. The US28-specific transcripts and CLTs are indicated
below the genome at a smaller scale by open arrows. The positions and
polarity of the US28-, as well as the CLT-specific RT-PCR primers
(Table 1) are indicated by black arrows. Transcription starts of the
sense CLTs (LSS1 and LSS2) and the PSS are indicated by arrowheads.
|
|
 |
MATERIALS AND METHODS |
Cells and virus.
Primary HFF, the human fibroblast cell line
MRC5, and the myeloid cell lines K562, KG1a, HL-60, U937, and THP-1
cells were cultured as described previously (4, 14, 44).
Stocks of wild-type (Toledo) and a US27-US28 double deletion mutant
virus (RV101) (4) were generated by propagation in HFF and
MRC5 (4). For reverse transcription (RT)-PCR analysis,
virions from HFF culture medium samples, each containing 3 × 106 PFU of either Toledo or RV101 HCMV per ml, were
separated from cellular debris by low-speed centrifugation (10 min at
10,000 × g, 4°C) and pelleted by ultracentrifugation
(30 min at 100,000 × g, 4°C). A sample of Toledo
virus was inactivated by irradiation with 4.7 J of UV using a
Stratalinker UV Crosslinker 1800 (Stratagene Cloning Systems,
Amsterdam, The Netherlands).
RT-PCR.
Primers specific for either the HCMV US28 gene
(US28F and US28R), both sense (CLTF1, CLTF2, CLTR1, and CLTR2) and
anti-sense CLTs (ANTICLTF and ANTICLTR); the HCMV DNA polymerase gene
UL54 (DNAPOLF* and DNAPOLR*, and a supplemental set, DNAPOLF and
DNAPOLR); or the human glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) gene (GAPDHF and GAPDHR) were obtained from Eurogentec
(Eurogentec, Seraing, Belgium). The nucleotide sequences of these
primers are shown in Table 1. The
positions of the CLT-specific and US28-specific primers relative to
their corresponding transcripts are shown in Fig. 1. Primers CLTR1 and
CLTR2 were derived from nucleotide sequences within CLT exon 3 and exon
2, respectively (Fig. 1). Primers CLTF1 and CLTF2 were derived from the
sequence between the latency-specific transcription start site 2 (LSS2)
and the PSS (Fig. 1). The sequences of primer ANTICLTF and ANTICLTR are collinear with MIE intron sequences and can therefore not detect mature
sense CLTs (Fig. 1). However, it may be possible that these primers
amplify either sense-polarized MIE-specific transcripts that have not
been identified before, or immature CLTs containing intron sequences.
Both possibilities should be taken into consideration for every
reference to antisense CLTs in this report. Each target sample for
RT-PCR was obtained by isolation of poly(A)+ RNA from 5 × 106 cells using a QuickPrep Micro mRNA purification kit
(Amersham Pharmacia Biotech, Saclay, France). Subsequently,
poly(A)+ RNA samples were treated with DNase I (Amersham
Pharmacia Biotech) according to the manufacturer's protocol. They were
then reverse transcribed using an Advantage RT-for-PCR Kit
(Clontech-Ozyme, Montigny-Le-Bretonneux, France). RT was primed with
oligo(dT) primers included in the kit. Aliquots of the resulting cDNA
that corresponded to 2 × 105 cells were added to PCR
mixtures. PCR mixtures were prepared using AdvanTaq Plus DNA Polymerase
kit (Clontech-Ozyme) according to the manufacturer's protocol. Thermal
cycling conditions were similar for PCRs with all primer sets mentioned
(2 min of denaturation at 94°C, followed by 50 cycles of 5 s
at 94°C and 30 s at 70°C), except for those for the GAPDH- and
HCMV DNA polymerase-specific (DNAPOLF and DNAPOLR) primer sets,
which were 2 min of denaturation at 94°C, followed by 50 cycles of
5 s at 94°C and 30 s at 68°C. Thermal cycling was done
with a GeneAmp PCR System 9600 thermal cycler (Perkin-Elmer,
Courtaboeuf, France). PCR products were visualized by agarose gel
electrophoresis and ethidium bromide staining.
Indirect immunocytometry.
The following monoclonal
antibodies (MAb) were used for HCMV antigen detection in both MRC5 and
THP-1 cells: (i) MAb E13 (a kind gift from M. C. Mazeron,
Hôpital Lariboisière, Paris, France), which detects both
HCMV immediate early 1 and 2 antigens; (ii) MAb F6a, which detects the
HCMV early antigen ppUL83 (pp65) (Michelson et al., unpublished data);
and (iii) an anti-pp150 MAb (a kind gift from H. P. Hartus,
Universität Erlangen-Nürnberg, Erlangen, Germany), which
detects the HCMV late antigen ppUL32 (pp150) (17). The
secondary antibodies used were fluorescein-conjugated sheep anti-mouse
immunoglobulin G (Amersham Pharmacia Biotech) for the detection of MAb
F6a and fluorescein-conjugated goat anti-mouse immunoglobulin G (CALTAG
Laboratories, Burlingame, Calif.) for the detection of MAb E13 and MAb
anti-pp150. Samples containing 106 uninfected or
HCMV-infected cells of either MRC5 or THP-1 origin were permeabilized
in permeabilization buffer (phosphate-buffered saline with 0.2% bovine
serum albumin [Sigma-Aldrich Chemie, Steinheim, Germany] and 0.05%
saponin [Sigma-Aldrich Chemie]) for 20 min at room temperature. All
subsequent incubations were done in permeabilization buffer at 4°C.
Cells were incubated for 30 min with 5 µg of primary MAb per ml,
washed two times, and stained with secondary MAb according to the
manufacturer's protocol. Finally, the cells were fixed in
phosphate-buffered saline with 4% formaldehyde and subjected to flow
cytometry using a FACSCalibur flow cytometer (Becton Dickinson Immunocytometry Systems, La Pond-de Claix, France). Data were analyzed
using the CELL Quest flow cytometry analysis program (version 3.3;
Becton Dickinson Immunocytometry Systems).
 |
RESULTS |
Detection of HCMV-specific transcripts in various infected myeloid
cell lines.
Previously, both HCMV-specific DNA and RNA in latently
infected individuals were detected using PCR techniques. Genomic HCMV DNA can be detected in approximately 0.01% of mononuclear cells in
blood and BM samples from naturally infected individuals (19, 36,
39), whereas between 0.01 and 0.001% of BM-derived
CD33+ CD14+ and CD33+
CD15+ cells contain CLTs (13). Similar to the
techniques used for the detection of genomic HCMV DNA in these cells,
we developed an RT-PCR system to enable detection of HCMV-specific
transcripts during latent infection in vitro. In order to determine the
type of cell that would be suitable for establishing latent HCMV
infection in vitro, we screened several infected myeloid cells lines
for the presence of US28-specific transcripts and antisense CLTs. Each
of these lines represents a specific differentiation stage in
hematopoiesis toward monocytes: K562 cells (very early pluripotent hematopoietic stem cells), KG1a (pluripotent CD34+
hematopoietic stem cell-like), HL-60 (monocyte or granulocyte progenitor-like), U937 (promonocytic), and THP-1 (monocytic) (reviewed by Harris 14). Cells (5 × 107 per
sample) were infected with HCMV strain Toledo at a multiplicity of infection (MOI) of 4. On day 4 p.i., culture medium was
refreshed. Finally, on day 8 p.i., cells were harvested and
subjected to RT-PCR. Whereas all cDNA samples were positive for GAPDH
transcripts with the expected size of 235 bp (Fig.
2A, lanes 2 to 11, upper panel), only the
sample containing cDNA from the infected THP-1 monocytic cell line was
PCR positive for both US28 transcripts (Fig. 2A, lane 10, middle panel;
expected size = 298 bp) and antisense CLT (Fig. 2A, lane 10, lower
panel; expected size = 469 bp). Fresh samples were subjected to a
new round of PCR in which various combinations of sense CLT-specific
primer pairs were included (Fig. 1). As shown in Fig. 2B, PCR mixtures
containing either primer pairs CLTF1 and CLTR1, CLTF2 and CLTR1, or
CLTF1 and CLTR2 each produced products that matched the expected sizes
of 436, 368, and 297 bp, respectively (Fig. 2B, lanes 2 to 4). In
contrast, PCR samples containing the primer combination of CLTF2 and
CLTR2 (expected PCR product size = 229 bp) remained negative,
possibly due to incompatibility of the PCR primer pair (Fig. 2B, lane
5). Nonetheless, these results indicate that HCMV-infected THP-1 cells harbor US28-specific transcripts, as well as sense and anti-sense CLTs
at day 8 p.i. We were also able to detect these transcripts at a
later time point. Both US28- and antisense CLT-specific RT-PCR signals
were obtained from samples of infected THP-1 cells at day 15 p.i.
(Fig. 2C, lanes 7 and 10). We therefore focused on HCMV gene expression
in THP-1 cells in subsequent experiments.

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 2.
The US28 and MIE genes are transcribed in HCMV-infected
THP-1 cells. The figure shows ethidium bromide-stained 2% agarose gels
in which RT-PCR samples were separated. All agarose gel images shown in
this report were digitized and contrast-inverted for clarity using a
video scanner (Virbert Lourmat, Marne la Vallée, France).
Molecular weight (MW) marker sizes are indicated on the left of each
panel, and the primer sets corresponding to each panel are indicated on
the right. Black arrowheads denote the relevant PCR products. (A)
Detection of GAPDH-specific transcripts, antisense CLT-specific, and
US28-specific transcripts in a panel of HCMV-infected myeloid cell
types at day 8 p.i. The cell types used are indicated above the
panel using the following abbreviations: H, HL-60; K5, K562; KG, KG1a;
T, THP-1; U, U937. RT, sample not treated with reverse transcriptase.
(B) Detection of sense CLTs from HCMV-infected THP-1 cells at day
8 p.i. The primer combinations that were used in this experiment
(see also Table 1 and Fig. 1) are indicated above each lane. (C)
Detection of GAPDH-specific transcripts, anti-sense CLT-specific, and
US28-specific transcripts in HCMV-infected THP-1 cells at day 15 p.i. M, mock infected; I, HCMV Toledo infected.
|
|
US28 is transcribed de novo in THP-1 cells at late time points
p.i.
Although we were able to detect viral transcripts in THP-1
cells by RT-PCR, we did not exclude the possibility that these transcripts could be deposited by virions into the target cells upon
inoculation. To examine whether US28-specific mRNA can be deposited in
THP-1 cells, we prepared virions from both HCMV Toledo and a (negative
control) US27-US28 deletion mutant strain, RV101 (4), and
subjected these to RT-PCR analysis. Poly(A)+ RNA was
isolated from the virion preparations and subsequently reverse
transcribed and included in PCR mixtures containing either US28- or
GAPDH-specific primers. Surprisingly, both US28- and GAPDH-specific
transcripts were detected in mixtures from the Toledo samples (Fig.
3A), indicating that the viral inoculum
contains both viral and host cell-specific poly(A)+ RNA.
Consequently, it is possible that both types of RNA can be deposited
either at the cell surface of inside THP-1 cells upon inoculation. To
examine transfer of mRNA from the inoculum to the target cells, we
infected THP-1 cells that were treated with actinomycin D (10 µg/ml,
1 h before, during, and after infection) to block de novo RNA
synthesis. In addition, untreated THP-1 cells were inoculated with
either UV-inactivated or intact HCMV. Samples of these THP-1 cultures
were analyzed by RT-PCR at 1 h and 1 day p.i. Both US28- and
GAPDH-specific transcripts could be detected in actinomycin-D-treated
cells at 1 h p.i. (Fig. 3B, lane 1), whereas the
actinomycin-D-treated cells at day 1 p.i. were PCR negative (Fig.
3B, lane 4). This indicates that although both US28- and GAPDH-specific
mRNA are deposited either at the cell surface or inside THP-1 cells
upon infection, the transcripts cannot persist for 1 day in these
cells. Similar results were obtained by infection with UV-inactivated
virus. US28-specific transcripts could be detected in THP-1 cells
treated with inactivated virus at 1 h p.i. but not at day 1 p.i. (Fig. 3B, lanes 2 and 5, respectively). In contrast, transcripts
were detected at each of these time points in cells infected with
untreated virus (Fig. 3B, lanes 3 and 6). Taken together, we conclude
that US28 is transcribed de novo in THP-1 cells at very late time
points (8 to at least 15 days) p.i.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 3.
US28-specific transcripts are deposited either inside or
at the surface of THP-1 cells immediately after infection but
transcribed de novo at later times p.i. RT-PCR samples are visualized
on agarose gels as described in Fig. 2. (A) Detection of viral and
cellular poly(A)+ RNA in virus inoculum from HCMV-infected
fibroblasts. The primer sets that were included in the RT-PCR samples
are indicated on top of the panel. (B) Detection of US28-specific
transcripts either in actinomycin-D-treated HCMV-infected THP-1 cells
or in THP-1 cells infected with UV-inactivated HCMV. The primer sets
that were included in the RT-PCR samples are indicated at the right of
each panel. Samples from which reverse transcriptase enzyme was omitted
remained PCR negative (data not shown). Abbreviations: RT, sample
not treated with reverse transcriptase; +RT, reverse
transcriptase treated; , HCMV RV101 (US27-US28 deletion
mutant) virions; WT, wild-type HCMV; h, hours p.i.; d, days p.i.; A,
actinomycin D treated; UV, UV-treated; NT, not treated.
|
|
Detection of lytic HCMV antigens in infected THP-1 cells.
HCMV
infection in unstimulated THP-1 cells was previously defined as
abortive. This was based on experiments indicating the absence of HCMV
antigen expression (16, 22, 41, 44), probably due to
repression of the MIE promoter-enhancer (35). However, subtle differences in culture conditions may result in the presence of
small numbers of differentiated cells harboring replicating HCMV in an
infected THP-1 population. Consequently, US28-specific transcripts and
CLTs could be synthesized in a small fraction of productively rather
than latently infected cells. To determine whether in our system a
fraction of the HCMV-treated THP-1 culture contains reproductively
infected cells, we subjected a large quantity (5 × 105 per sample) of HCMV-treated THP-1 cells to
immunocytometric analysis. An assay was set up to enable detection of
antigens representing all phases of the lytic HCMV infection program,
including pUL122 and pUL123 (the MIE 1 and 2 transactivator antigens),
ppUL83 (a dominant early-phase tegument phospoprotein pp65), and ppUL32 (a dominant late-phase tegument phosphoprotein pp150). By using this
assay, each of these antigens was detected at day 2 p.i. in MRC5
fibroblasts that were infected at an MOI of 0.1 but not at day 7 p.i. in THP-1 monocytes that were infected at an MOI of 4 (Fig.
4). These results indicate that the
absence of lytic HCMV antigens in THP-1 cells is inadequate to define
abortive infection, considering that both US28-specific transcripts and CLTs were detected in these cells. Instead, the detection of gene transcription in the absence of lytic HCMV antigens may indicate latent infection. Nevertheless, productively infected THP-1
cells may be present at levels below the level of antigen detection by
immunocytometry. Therefore, as described in the section below, an
alternative standard is needed to determine whether the US28-specific transcripts occur in productively or latently infected cells.

View larger version (25K):
[in this window]
[in a new window]
|
FIG. 4.
Expression of lytic-phase antigens in HCMV-infected
THP-1 cells at day 7 p.i. The top panels show immunocytometric
histograms of HCMV-infected MRC5 fibroblasts (total cell count = 10,000) at day 2 p.i. The lower panels show histograms of infected
THP-1 cells (total cell count = 500,000) at day 7 p.i. FL1-H,
relative intensity of fluorescence. Dotted lines represent uninfected
cells.
|
|
Quantitative assessment of HCMV transcripts in infected THP-1
cells.
Latent HCMV infection, as opposed to productive infection,
implicates the absence of factors enabling viral replication, possibly including those required for viral genomic DNA
replication. Here, we set out to determine whether
US28-transcribing HCMV-infected THP-1 cells contain such factors.
For this purpose, we designed an RT-PCR assay to compare the
transcription levels of US28 with those of the UL54 HCMV DNA
polymerase gene in infected THP-1 cells. Initially, the sensitivity of
both US28- and UL54-specific RT-PCR assays (each utilizing either
US28F-US28R or DNAPOLF*-DNAPOLR*, respectively [Table 1])
were determined. This was done by applying RT-PCR to target cDNA
serially diluted in a cDNA background corresponding to 2 × 105 of uninfected THP-1 cells. Positive RT-PCR signals were
obtained in samples initially containing a minimum of 10 copies of
either US28specific (Fig. 5A, lanes 1 to
5, upper panel) or UL54-specific (Fig. 5A, lanes 1 to 5, lower panel;
expected size = 245 bp) cDNA. These results indicate that the
US28- and UL54-specific RT-PCR assays have similar sensitivities.
Subsequently, we determined the amount of HCMV-infected THP-1 cells
containing either US28- or UL54-specific transcripts at day 7 p.i.: cDNA samples were obtained from a panel of HCMV-treated THP-1
cells serially diluted with untreated cells corresponding to a total of
2 × 105 cells. These samples were subjected to RT-PCR
analysis. Consequently, we found that the HCMV-treated THP-1 cell
culture could be diluted at least 10-fold before the corresponding
US28-specific RT-PCR signal was lost (Fig. 5, lanes 1 to 6, upper
panel). This indicates that US28 is transcribed in at least 1 out of
2 × 104 HCMV-treated THP-1 cells. Surprisingly, we
were also able to detect UL54-specific transcripts in HCMV-infected
THP-1 cells. However, these transcripts could only be detected in the
undiluted culture sample (Fig. 5, lanes 1 to 6, middle panel). Since
both assays were shown to have similar sensitivities, we conclude that US28-transcribing cells are in 10-fold excess of UL54-transcribing cells within an HCMV-infected THP-1 culture at day 7 p.i. Next, we
set out to compare the levels of US28 and UL54 transcription in the
total cDNA fraction corresponding to 2 × 105 THP-1
cells. For this purpose, a series of diluted cDNA samples from THP-1
cells at day 7 p.i. was subjected to RT-PCR analysis. In effect,
US28-specific transcripts could be detected in cDNA samples that were
diluted up to 1,000-fold (Fig. 5C, lanes 1 to 6, upper panel).
In contrast, UL54-specific transcripts could only be
detected in undiluted samples (Fig. 5C, lanes 1 to 6, middle panel),
indicating that the level of US28 transcription is 1,000-fold that
of UL54.

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 5.
Quantitative comparison of US28 and HCMV DNA polymerase
gene transcription in HCMV-infected THP-1 cells at day 7 p.i.
RT-PCR samples are visualized on agarose gels as described in Fig. 2.
The primer sets that correspond to each of the panels are indicated on
the right of each panel. Black arrowheads denote the relevant PCR
products. (A) Sensitivity of RT-PCR for the detection of US28 and HCMV
DNA polymerase cDNA. The amount of target cDNA molecules that was
included in each RT-PCR sample is indicated at the top. (B)
Quantification of HCMV-infected THP-1 cells transcribing either US28 or
the HCMV DNA polymerase gene at day 7 p.i. The quantities on top
correspond to the amount of cells that were taken from the original
HCMV-infected THP-1 culture and mixed with uninfected THP-1 cells to a
total of 2 × 105 prior to cDNA preparation and RT-PCR. (C)
Quantification of US28- and HCMV DNA polymerase-specific transcripts in
untreated and PAA-treated HCMV-infected THP-1 cells at day 7 p.i. The
dilution factor of each cDNA sample relative to an initial sample
representing 2 × 105 cells is indicated on the top.
Abbreviations: M, mock-infected; I, HCMV-infected; I/PAA, infected and
PAA-treated; RT, sample not treated with reverse transcriptase.
|
|
Since the amount of cells transcribing US28 was estimated to be 10-fold
that of UL54-transcribing cells, it is possible that
the HCMV-treated
THP-1 culture contains both a latently and a
productively infected
fraction. Alternatively, the US28-positive-UL54-negative
fraction
could represent THP-1 cells that absorbed HCMV particles
that were
passed on by neighboring UL54-positive cells at a late
time point in
culture. The US28-positive-UL54-negative fraction
might therefore be
productively infected, albeit at an early stage
of infection in which
UL54 transcription is not yet manifest.
To determine whether US28
transcription is the result of such
a productive infection phenomenon,
we assessed US28 transcription
in HCMV-treated THP-1 cells treated with
a viral DNA replication
inhibitor. THP-1 cells were infected as
described above. At 4
h p.i., phosphonoacetic acid (PAA) was added to
the culture medium
at a final concentration of 200 µg/ml. PAA
treatment was maintained
until the cells were harvested at day 7 p.i. The inhibitory potential
of PAA was confirmed by assessing
inhibition of pp150 synthesis
in HCMV-infected MRC5 fibroblasts using
immunocytometry (data
not shown). RT-PCR was performed on
serially diluted cDNA samples
derived from HCMV-infected
PAA-treated THP-1 cells. Interestingly,
US28-specific signals were
obtained in samples diluted as much
as 1,000-fold (Fig.
5C, lanes 7 to
12, upper panel), similar to
what was found for infected cells that
were not treated with PAA
(Fig.
5C, lanes 1 to 6, upper panel). To
check whether PAA treatment
had no effect on the natural cellular
transcription level, the
dilution series from both untreated and
PAA-treated cells were
subjected to RT-PCR using GAPDH-specific
primers. Levels of GAPDH
transcription were found to be similar for
both samples (Fig.
5C, lanes 1 to 12, lower panel), indicating that
US28 transcript
levels are also similar. Surprisingly, RT-PCR signals
for UL54
could not be observed in cDNA samples from PAA-treated cells,
whereas the undiluted sample of untreated HCMV-infected cells
was
RT-PCR positive (Fig.
5, lanes 1 to 12, middle panel). Although
PAA
treatment affects HCMV DNA polymerase activity, we did not
expect UL54
transcript levels to be lower in PAA-treated cells
than in untreated
cells. This might indicate that UL54 transcription
is propelled by a
late-phase positive feedback mechanism. We did
not investigate
this possibility further. Nevertheless, we have
shown that (i)
US28 is transcribed in HCMV-infected THP-1 cells
at least until day
15 p.i., (ii) the amount of US28-transcribing
THP-1 cells is
approximately 10-fold that of UL54-transcribing
cells at day 7 p.i., and (iii) detection of US28 transcription
is irrespective of
viral replication in HCMV-infected THP-1 cells.
These results indicate
that US28 is transcribed in latently infected
THP-1
monocytes.
US28 transcription in differentiated THP-1 cells.
In addition
to demonstrating that the HCMV US28 gene is transcribed during latent
infection in undifferentiated THP-1 monocytes, we set out to determine
whether US28 transcription also occurs in differentiated cells.
Previously, HCMV-infected monocyte-derived macrophages were shown to
support viral replication (22, 37, 40). Therefore, we also
assessed the replication status of the HCMV-infected cells by
determining whether the HCMV DNA polymerase gene UL54 would be
upregulated upon differentiation. First, THP-1 cells were infected with
HCMV as described above, and then a culture sample was treated with
phorbol-12-myristate-13-acetate (PMA) (50 ng/ml) from 0 to 72 h p.i. In
contrast to untreated THP-1 cells, PMA-treated THP-1 cells became
adherent after several hours of stimulation (data not shown). Such an
adhesion phenotype is typical for differentiation of monocytic cells
(14). At days 1, 5, and 7 p.i., both US28 and UL54
transcription were assessed in cDNA samples derived from untreated and
PMA-treated THP-1 cultures. Alternative primers for UL54 transcript
detection, DNAPOLF and DNAPOLR (Table 1), were used for RT-PCR,
resulting in an assay less sensitive than RT-PCR with the
aforementioned DNAPOLF* and DNAPOLR* primers (Table 1). As a result,
UL54-transcripts could not be detected in undifferentiated
HCMV-infected THP-1 cells (Fig. 6, lanes
1 to 3, middle panel). In contrast, by using these primers, UL54
transcripts were detected in differentiated THP-1 cells at all time
points (Fig. 6, lanes 4 to 6, middle panel). These results confirm
upregulation of UL54 transcription and possibly HCMV replication upon
differentiation of THP-1 cells. Finally, we were able to detect US28
transcript in both untreated and PMA-treated HCMV-infected cells at all
time points mentioned (Fig. 6, lanes 1 to 6, upper panel). We therefore
conclude that, in addition to transcription in latently infected THP-1
monocytes, US28 transcription is sustained in infected THP-1 cells
throughout differentiation into adherent, macrophage-like cells.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 6.
Transcription of US28 and the HCMV DNA polymerase gene
in undifferentiated (untreated) and differentiated (PMA-treated) THP-1
cells. RT-PCR samples are visualized on agarose gels as described in
Fig. 2. The primer sets that correspond to each of the panels are
indicated on the right. The time points (p.i.) at which samples were
taken for RT-PCR are shown at the top. d, days p.i.
|
|
 |
DISCUSSION |
To date, both US28 transcripts and CLTs are the only transcripts
identified in myeloid cells that are latently infected with HCMV. Yet,
they are also present in productively infected cells (4, 24, 42,
43, 44) and are therefore not explicit markers of latency. To
determine whether cells are latently infected with HCMV, the presence
of either viral DNA or RNA from candidate latency-associated genes
should be demonstrated in parallel to the absence of virus production.
In this report, we considered the presence of HCMV DNA polymerase UL54
transcripts to be a determinant of productive infection. However, this
determinant could prove to be too stringent; in addition to being a
marker for productive infection, it could indicate viral DNA
replication during latency, such as in a self-renewing HCMV-infected
myeloid cell population. Nevertheless, we showed that the majority of
US28-transcribing THP-1 cells does not contain UL54-specific
transcripts. Moreover, US28 transcription levels were not affected in
the presence of an HCMV DNA replication inhibitor. These findings
indicate that this majority of US28-transcribing THP-1 cells are
latently infected. Similar conditions could be used as a standard for
identifying other latency-associated transcripts. Thus, a strict
definition of latency could comprise (i) the absence of UL54-specific
transcripts and (ii) candidate HCMV gene transcription irrespective of
viral DNA replication. Nonetheless, UL54 transcription does not
necessarily exclude latency. Its role in viral genome replication
during latent infection will have to be addressed in future studies.
We demonstrated that the lytic phase antigens IE1-IE2, pp65, and pp150
were present at levels below the detection level in undifferentiated
THP-1 cells and that HCMV DNA polymerase UL54 transcription levels were
higher in differentiated cells than in undifferentiated THP-1 cells.
Similarly, it was previously shown that MIE protein levels are higher
in differentiated THP-1 cells that were infected with HCMV than in less
differentiated cells (23). In addition, the generation of
HCMV particles could not be demonstrated in monocytes, whereas
replication was demonstrated in monocyte-derived macrophages and
dendritic cells (34, 37). Thus, the relative degree of
monocyte differentiation may be an important factor for regulation of
HCMV gene expression. This explains why in our study US28 transcripts
were not detected in K562, KG1a, HL-60, and U937 cells, which are less
differentiated than the monocyte-type THP-1 cells. In addition to
containing US28 and the MIE gene, the HCMV genome may contain many
other genes that could concert latency and replication in myeloid
cells. However, the low amount of infected (relative to unifected)
myeloid precursors and the low-level transcription of HCMV genes during latent infection currently limit the study of HCMV gene expression in
vivo to RT-PCR analysis. In the future, a sensitive immunological assay
will have to be developed to confirm expression of viral proteins
during latent HCMV infection in monocytes.
In this report we demonstrated that HCMV inoculum contains both viral
and host cell RNA. We did not determine further whether the
poly(A)+ RNA originated from virions or cellular debris
associated with the virions. However, Greijer et al. (12)
recently reported that both viral and host cell RNA molecules can be
detected in sucrose density step-gradient-purified HCMV virions.
Furthermore, they showed that virion-associated RNA can be deposited
either at the surface of or inside inoculated fibroblasts upon
inoculation. RNA could be detected after 1 h, but not at 4 h
or at later time points p.i.
similar to our observation that
virus-associated transcripts can be deposited in or on THP-1 cells upon
infection but that these transcripts do not persist in or on these
cells for more than 1 day p.i.
Kledal et al. (18) reported that pUS28 is capable of
binding soluble forms of the CX3C chemokine fractalkine (or
neurotactin) with subnanomolar affinity. This chemokine exists both in
a soluble and a cell membrane-bound form. The membrane-bound form
consists of a chemokine domain, a mucin stalk, a transmembrane and an
intracellular domain (1, 28). Interestingly, it appears to
combine the properties of both chemoattractants and adhesion molecules.
Fractalkine is expressed at the surface of activated endothelium,
thereby enabling leukocyte capture, firm integrin-independent adhesion, and attachment of circulating monocytes under flow conditions (7,
9). Additionally, it was shown that pUS28-expressing 300-19 murine pre-B cells could be captured by a fractalkine- or stalk-coated
surface under physiological flow conditions (15). Although
many CC chemokines can bind pUS28 (4, 10, 21, 26),
fractalkine has the highest affinity, as well as a slow off-rate for
this receptor (15, 18). In this report it was shown that
US28 is transcribed in monocytic cells that harbor latent HCMV. Thus,
expression of the US28 gene could play a role in the tethering of
latently infected circulating monocytes to endothelial tissue
expressing membrane-bound fractalkine. Alternatively, pUS28 could guide
latently infected monocytes to other tissues expressing fractalkine or
CC chemokines by chemotaxis. Fractalkine is shed from intestinal
epithelial cells upon stimulation with interleukin 1
(25). Moreover, membrane-bound fractalkine is expressed by skin-derived dendritic and Langerhans cells
(30), as well as by skin endothelial cells and dermal
dendrocytes (29). These cell types are permissive for
productive HCMV infection and therefore potential targets for
monocyte-mediated HCMV dissemination. Finally, monocytes mature into
either macrophages or dendritic cells upon migration into target
tissues (14). We showed that transcription of US28
persists during differentiation of THP-1 cells by stimulation with PMA.
It is therefore possible that pUS28 continues to guide infected
monocytes during their differentiation in the target tissues. Further
studies require the development of suitable antibodies against the US28
gene product. By using these antibodies, pUS28 surface expression on
latently infected monocytes from healthy individuals could be
confirmed, as well as pUS28-dependent interaction of these cells with
the endothelium and other potential target tissues. Hence, an
intriguing function of pUS28 in the dissemination of latent HCMV may be established.
 |
ACKNOWLEDGMENTS |
We thank Maria-Paola Landini for the kind gift of Toledo virus
and Tom Jones for providing the deletion mutant RV101. We also thank
Françoise Bachelerie and Agustin Valenzuela-Fernandez for critically reading the manuscript.
P.S.B. is a beneficiary of a research fellowship from the European
Molecular Biology Organization, Heidelberg, Germany. This work was
supported by the Agence National de la Recherche contre le SIDA.
 |
FOOTNOTES |
*
Corresponding author. Present address: Department of
Medical Microbiology, University Hospital of Maastricht, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands. Phone: 31 43 3876644. Fax: 31 43 3876643. E-mail: pbe{at}lmib.azm.nl.
 |
REFERENCES |
| 1.
|
Bazan, J. F.,
K. B. Bacon,
G. Hardiman,
W. Wang,
K. Soo,
D. Rossi,
D. R. Greaves,
A. Zlotnik, and T. J. Schall.
1997.
A new class of membrane-bound chemokine with a CX3C motif.
Nature
385:640-644[CrossRef][Medline].
|
| 2.
|
Billstrom, M. A.,
G. L. Johnson,
N. J. Avdi, and G. S. Worthen.
1998.
Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection.
J. Virol.
72:5535-5544[Abstract/Free Full Text].
|
| 3.
|
Billstrom, M. A.,
L. A. Lehman, and G. S. Worthen.
1999.
Depletion of extracellular RANTES during human cytomegalovirus infection of endothelial cells.
Am. J. Respir. Cell Mol. Biol.
21:163-167[Abstract/Free Full Text].
|
| 4.
|
Bodaghi, B.,
T. R. Jones,
D. Zipeto,
C. Vita,
L. Sun,
L. Laurent,
F. Arenzana-Seisdedos,
J. L. Virelizier, and S. Michelson.
1998.
Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus-infected cells.
J. Exp. Med.
188:855-866[Abstract/Free Full Text].
|
| 5.
|
Bolovan-Fritts, C. A.,
E. S. Mocarski, and J. A. Wiedeman.
1999.
Peripheral blood CD14+ cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome.
Blood
93:394-398[Abstract/Free Full Text].
|
| 6.
|
Casarosa, P.,
R. A. Bakker,
D. Verzijl,
M. Navis,
H. Timmerman,
R. Leurs, and M. J. Smit.
2001.
Constitutive signalling of the human cytomegalovirus-encoded chemokine receptor US28.
J. Biol. Chem.
276:1133-1137[Abstract/Free Full Text].
|
| 7.
|
Chapman, G. A.,
K. E. Moores,
J. Gohil,
T. A. Berkhout,
L. Patel,
P. Green,
C. H. Macphee, and B. R. Stewart.
2000.
The role of fractalkine in the recruitment of monocytes to the endothelium.
Eur. J. Pharmacol.
392:189-195[CrossRef][Medline].
|
| 8.
|
Chee, M. S.,
S. C. Satchwell,
E. Preddie,
K. M. Weston, and B. G. Barrell.
1990.
Human cytomegalovirus encodes three G protein-coupled receptor homologues.
Nature
344:774-777[CrossRef][Medline].
|
| 9.
|
Fong, A. M.,
L. A. Robinson,
D. A. Steeber,
T. F. Tedder,
O. Yoshie,
T. Imai, and D. D. Patel.
1998.
Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow.
J. Exp. Med.
188:1413-1419[Abstract/Free Full Text].
|
| 10.
|
Gao, J. L., and P. M. Murphy.
1994.
Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor.
J. Biol. Chem.
269:28539-28542[Abstract/Free Full Text].
|
| 11.
|
Gompels, U. A.,
J. Nicholas,
G. Lawrence,
M. Jones,
B. J. Thomson,
M. E. Martin,
S. Efstathiou,
M. Craxton, and H. A. Macaulay.
1995.
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution.
Virology
209:29-51[CrossRef][Medline].
|
| 12.
|
Greijer, A. E.,
C. A. J. Dekkers, and J. M. Middeldorp.
2000.
Human cytomegalovirus virions differentially incorporate viral and host cell RNA during the assembly process.
J. Virol.
74:9078-9082[Abstract/Free Full Text].
|
| 13.
|
Hahn, G.,
R. Jores, and E. S. Mocarski.
1998.
Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells.
Proc. Natl. Acad. Sci. USA
95:3937-3942[Abstract/Free Full Text].
|
| 14.
|
Harris, P.
1996.
Human myeloid cell lines, p. 173.1-173.16.
In
L. Herzenberg, and C. Blackwell (ed.), The integrated immune system, 5th ed., vol. IV. Blackwell Science, Cambridge, Mass.
|
| 15.
|
Haskell, C. A.,
M. D. Cleary, and I. F. Charo.
2000.
Unique role of the chemokine domain of fractalkine in cell capture: kinetics of receptor dissociation correlate with cell adhesion.
J. Biol. Chem.
275:34183-34189[Abstract/Free Full Text].
|
| 16.
|
Huang, T. H.,
T. Oka,
T. Asai,
T. Okada,
B. W. Merrills,
P. N. Gertson,
R. H. Whitson, and K. Itakura.
1996.
Repression by a differentiation-specific factor of the human cytomegalovirus enhancer.
Nucleic Acids Res.
24:1695-1701[Abstract/Free Full Text].
|
| 17.
|
Jahn, G.,
H. P. Harthus,
M. Broker,
B. Borisch,
B. Platzer, and B. Plachter.
1990.
Generation and application of a monoclonal antibody raised against a recombinant cytomegalovirus-specific polypeptide.
Klin. Wochenschr.
68:1003-1007[CrossRef][Medline].
|
| 18.
|
Kledal, T. N.,
M. M. Rosenkilde, and T. W. Schwartz.
1998.
Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28.
FEBS Lett.
441:209-214[CrossRef][Medline].
|
| 19.
|
Kondo, K.,
H. Kaneshima, and E. S. Mocarski.
1994.
Human cytomegalovirus latent infection of granulocyte-macrophage progenitors.
Proc. Natl. Acad. Sci. USA
91:11879-11883[Abstract/Free Full Text].
|
| 20.
|
Kondo, K.,
J. Xu, and E. S. Mocarski.
1996.
Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals.
Proc. Natl. Acad. Sci. USA
93:11137-11142[Abstract/Free Full Text].
|
| 21.
|
Kuhn, D. E.,
C. J. Beall, and P. E. Kolattukudy.
1995.
The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity.
Biochem. Biophys. Res. Commun.
211:325-330[CrossRef][Medline].
|
| 22.
|
Lashmit, P. E.,
M. F. Stinski,
E. A. Murphy, and G. C. Bullock.
1998.
A cis repression sequence adjacent to the transcription start site of the human cytomegalovirus US3 gene is required to down regulate gene expression at early and late times after infection.
J. Virol.
72:9575-9584[Abstract/Free Full Text].
|
| 23.
|
Lee, C. H.,
G. C. Lee,
Y. J. Chan,
C. J. Chiou,
J. H. Ahn, and G. S. Hayward.
1999.
Factors affecting human cytomegalovirus gene expression in human monocyte cell lines.
Mol. Cells
9:37-44[Medline].
|
| 24.
|
Lunetta, J. M., and J. A. Wiedeman.
2000.
Latency-associated sense transcripts are expressed during in vitro human cytomegalovirus productive infection.
Virology
278:467-476[CrossRef][Medline].
|
| 25.
|
Muehlhoefer, A.,
L. J. Saubermann,
X. Gu,
K. Luedtke-Heckenkamp,
R. Xavier,
R. S. Blumberg,
D. K. Podolsky,
R. P. MacDermott, and H. C. Reinecker.
2000.
Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa.
J. Immunol.
164:3368-3376[Abstract/Free Full Text].
|
| 26.
|
Neote, K.,
D. DiGregorio,
J. Y. Mak,
R. Horuk, and T. J. Schall.
1993.
Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor.
Cell
72:415-425[CrossRef][Medline].
|
| 27.
|
Ohagen, A.,
L. Li,
A. Rosenzweig, and D. Gabuzda.
2000.
Cell-dependent mechanisms restrict the HIV type 1 coreceptor activity of US28, a chemokine receptor homolog encoded by human cytomegalovirus.
AIDS Res. Hum. Retrovirus.
16:27-35[CrossRef][Medline].
|
| 28.
|
Pan, Y.,
C. Lloyd,
H. Zhou,
S. Dolich,
J. Deeds,
J. A. Gonzalo,
J. Vath,
M. Gosselin,
J. Ma,
B. Dussault,
E. Woolf,
G. Alperin,
J. Culpepper,
J. C. Gutierrez-Ramos, and D. Gearing.
1997.
Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation.
Nature
387:611-617[CrossRef][Medline].
|
| 29.
|
Papadopoulos, E. J.,
D. J. Fitzhugh,
C. Tkaczyk,
A. M. Gilfillan,
C. Sassetti,
D. D. Metcalfe, and S. T. Hwang.
2000.
Mast cells migrate, but do not degranulate, in response to fractalkine, a membrane-bound chemokine expressed constitutively in diverse cells of the skin.
Eur. J. Immunol.
30:2355-2361[CrossRef][Medline].
|
| 30.
|
Papadopoulos, E. J.,
C. Sassetti,
H. Saeki,
N. Yamada,
T. Kawamura,
D. J. Fitzhugh,
M. A. Saraf,
T. Schall,
A. Blauvelt,
S. D. Rosen, and S. T. Hwang.
1999.
Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation.
Eur. J. Immunol.
29:2551-2559[CrossRef][Medline].
|
| 31.
|
Patterson, B. K.,
A. Landay,
J. Andersson,
C. Brown,
H. Behbahani,
D. Jiyamapa,
Z. Burki,
D. Stanislawski,
M. A. Czerniewski, and P. Garcia.
1998.
Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission.
Am. J. Pathol.
153:481-490[Abstract/Free Full Text].
|
| 32.
|
Pleskoff, O.,
C. Treboute,
A. Brelot,
N. Heveker,
M. Seman, and M. Alizon.
1997.
Identification of a chemokine receptor encoded by human cytomegalovirus as a cofactor for HIV-1 entry.
Science
276:1874-1878[Abstract/Free Full Text].
|
| 33.
|
Pleskoff, O.,
C. Treboute, and M. Alizon.
1998.
The cytomegalovirus-encoded chemokine receptor US28 can enhance cell-cell fusion mediated by different viral proteins.
J. Virol.
72:6389-6397[Abstract/Free Full Text].
|
| 34.
|
Riegler, S.,
H. Hebart,
H. Einsele,
P. Brossart,
G. Jahn, and C. Sinzger.
2000.
Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus.
J. Gen. Virol.
81:393-399[Abstract/Free Full Text].
|
| 35.
|
Sinclair, J. H.,
J. Baillie,
L. A. Bryant,
J. A. Taylor-Wiedeman, and J. G. Sissons.
1992.
Repression of human cytomegalovirus major immediate early gene expression in a monocytic cell line.
J. Gen. Virol.
73:433-435[Abstract/Free Full Text].
|
| 36.
|
Slobedman, B., and E. S. Mocarski.
1999.
Quantitative analysis of latent human cytomegalovirus.
J. Virol.
73:4806-4812[Abstract/Free Full Text].
|
| 37.
|
Söderberg-Naucler, C.,
K. N. Fish, and J. A. Nelson.
1998.
Growth of human cytomegalovirus in primary macrophages.
Methods
16:126-138[CrossRef][Medline].
|
| 38.
|
Streblow, D. N.,
C. Söderberg-Naucler,
J. Vieira,
P. Smith,
E. Wakabayashi,
F. Ruchti,
K. Mattison,
Y. Altschuler, and J. A. Nelson.
1999.
The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration.
Cell
99:511-520[CrossRef][Medline].
|
| 39.
|
Tanaka, N.,
H. Kimura,
K. Iida,
Y. Saito,
I. Tsuge,
A. Yoshimi,
T. Matsuyama, and T. Morishima.
2000.
Quantitative analysis of cytomegalovirus load using a real-time PCR assay.
J. Med. Virol.
60:455-462[CrossRef][Medline].
|
| 40.
|
Turtinen, L. W., and B. J. Seufzer.
1994.
Selective permissiveness of TPA differentiated THP-1 myelomonocytic cells for human cytomegalovirus strains AD169 and Towne.
Microb. Pathog.
16:373-378[CrossRef][Medline].
|
| 41.
|
Weinshenker, B. G.,
S. Wilton, and G. P. Rice.
1988.
Phorbol ester-induced differentiation permits productive human cytomegalovirus infection in a monocytic cell line.
J. Immunol.
140:1625-1631[Abstract].
|
| 42.
|
Welch, A. R.,
L. M. McGregor, and W. Gibson.
1991.
Cytomegalovirus homologs of cellular G protein-coupled receptor genes are transcribed.
J. Virol.
65:3915-3918[Abstract/Free Full Text].
|
| 43.
|
White, K. L.,
B. Slobedman, and E. S. Mocarski.
2000.
Human cytomegalovirus latency-associated protein pORF94 is dispensable for productive and latent infection.
J. Virol.
74:9333-9337[Abstract/Free Full Text].
|
| 44.
|
Zipeto, D.,
B. Bodaghi,
L. Laurent,
J. L. Virelizier, and S. Michelson.
1999.
Kinetics of transcription of human cytomegalovirus chemokine receptor US28 in different cell types.
J. Gen. Virol.
80:543-547[Abstract].
|
Journal of Virology, July 2001, p. 5949-5957, Vol. 75, No. 13
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.13.5949-5957.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Saffert, R. T., Kalejta, R. F.
(2007). Human Cytomegalovirus Gene Expression Is Silenced by Daxx-Mediated Intrinsic Immune Defense in Model Latent Infections Established In Vitro. J. Virol.
81: 9109-9120
[Abstract]
[Full Text]
-
Cheung, A. K. L., Abendroth, A., Cunningham, A. L., Slobedman, B.
(2006). Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood
108: 3691-3699
[Abstract]
[Full Text]
-
Sinclair, J., Sissons, P.
(2006). Latency and reactivation of human cytomegalovirus. J. Gen. Virol.
87: 1763-1779
[Abstract]
[Full Text]
-
Casarosa, P., Waldhoer, M., LiWang, P. J., Vischer, H. F., Kledal, T., Timmerman, H., Schwartz, T. W., Smit, M. J., Leurs, R.
(2005). CC and CX3C Chemokines Differentially Interact with the N Terminus of the Human Cytomegalovirus-encoded US28 Receptor. J. Biol. Chem.
280: 3275-3285
[Abstract]
[Full Text]
-
Slobedman, B., Stern, J. L., Cunningham, A. L., Abendroth, A., Abate, D. A., Mocarski, E. S.
(2004). Impact of Human Cytomegalovirus Latent Infection on Myeloid Progenitor Cell Gene Expression. J. Virol.
78: 4054-4062
[Abstract]
[Full Text]
-
Jenkins, C., Abendroth, A., Slobedman, B.
(2004). A Novel Viral Transcript with Homology to Human Interleukin-10 Is Expressed during Latent Human Cytomegalovirus Infection. J. Virol.
78: 1440-1447
[Abstract]
[Full Text]
-
Casarosa, P., Gruijthuijsen, Y. K., Michel, D., Beisser, P. S., Holl, J., Fitzsimons, C. P., Verzijl, D., Bruggeman, C. A., Mertens, T., Leurs, R., Vink, C., Smit, M. J.
(2003). Constitutive Signaling of the Human Cytomegalovirus-encoded Receptor UL33 Differs from That of Its Rat Cytomegalovirus Homolog R33 by Promiscuous Activation of G Proteins of the Gq, Gi, and Gs Classes. J. Biol. Chem.
278: 50010-50023
[Abstract]
[Full Text]
-
Streblow, D. N., Vomaske, J., Smith, P., Melnychuk, R., Hall, L., Pancheva, D., Smit, M., Casarosa, P., Schlaepfer, D. D., Nelson, J. A.
(2003). Human Cytomegalovirus Chemokine Receptor US28-induced Smooth Muscle Cell Migration Is Mediated by Focal Adhesion Kinase and Src. J. Biol. Chem.
278: 50456-50465
[Abstract]
[Full Text]
-
Casarosa, P., Menge, W. M., Minisini, R., Otto, C., van Heteren, J., Jongejan, A., Timmerman, H., Moepps, B., Kirchhoff, F., Mertens, T., Smit, M. J., Leurs, R.
(2003). Identification of the First Nonpeptidergic Inverse Agonist for a Constitutively Active Viral-encoded G Protein-coupled Receptor. J. Biol. Chem.
278: 5172-5178
[Abstract]
[Full Text]